HC Wainwright & Co. Reiterates Buy on Upstream Bio, Maintains $36 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Matthew Caufield reiterates Upstream Bio (NASDAQ:UPB) with a Buy and maintains $36 price target.